@article{029f1ab03f29435b9eda1f1ecb058375,
title = "When to treat myelodysplastic syndromes.",
author = "Mojtaba Akhtari",
note = "The myelodysplastic syndromes represent a heterogeneous series of clonal hematologic neoplasms characterized by morphologic dysplasia, aberrant hematopoiesis and a variable risk of progression to acute myeloid leukemia. These syndromes have a complex pathobiology, and ineffective hematopoiesis is a well-recognized feature of all of them.",
year = "2011",
month = may,
day = "1",
language = "American English",
volume = "25",
journal = "Oncology (Williston Park, N.Y.)",
issn = "0890-9091",
number = "6",
}